The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling

Development

Volumn 133, Issue 1, 2006, Pages 63-74

  Deckelbaum, Ron A ^a   Majithia, Amit ^a   Booker, Thomas ^a   Henderson, Janet E ^b   Loomis, Cynthia A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Calvarial bone; En1; Osteoblasts; Osteoclasts; Osterix

Indexed keywords

ENGRAILED 1 PROTEIN; FIBROBLAST GROWTH FACTOR; HOMEODOMAIN PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MINERALIZATION; BONE REMODELING; CALVARIA; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; EMBRYO; EMBRYO DEVELOPMENT; HYPOPLASIA; MESENCHYME; MOUSE; MOUSE MUTANT; NEWBORN; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPENIA; PERINATAL DEVELOPMENT; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SKULL DEVELOPMENT;

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANIMALS; BLOTTING, NORTHERN; BONE REMODELING; CARRIER PROTEINS; CELL DIFFERENTIATION; CELL PROLIFERATION; FIBROBLAST GROWTH FACTORS; HOMEODOMAIN PROTEINS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISOENZYMES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; OSTEOBLASTS; OSTEOGENESIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; SKULL; TOMOGRAPHY, X-RAY COMPUTED;

ANIMALIA; MAMMALIA;

EID: 31644437052     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.02171     Document Type: Article

References (60)

1. Atkins, G. J., Kostakis, P., Pan, B., Farrugia, A., Gronthos, S., Evdokiou, A., Harrison, K., Findlay, D. M. and Zannettino, A. C. (2003). RANKL expression is related to the differentiation state of human osteoblasts. J. Bone Miner. Res. 18, 1088-1098.
2. Aubin, J. E. and Triffit, J. T. (2002). Mesenchymal stem cells and osteoblast differentiation. In Principles of Bone Biology, Vol. 1 (ed. J. P. Bilezikian, L. G. Raisz and G. A. Rodan), pp. 59-81. New York: Academic Press.
3. Bakker, A. K.-N. and Jenneke. (2003). Osteoblast isolation from murine calvariae and long bones. In Bone Research Protocols (ed. M. H. R. Helfrich and H. Stuart), pp. 19-28. Totowa (NJ): Humana Press.
4. Chen, L., Li, D., Li, C., Engel, A. and Deng, C. X. (2003). A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis. Bone 33, 169-178.
5. Corson, L. B., Yamanaka, Y., Lai, K. M. and Rossant, J. (2003). Spatial and temporal patterns of ERK signaling during mouse embryogenesis. Development 130, 4527-4537.
6. Davidson, D., Graham, E., Sime, C. and Hill, R. (1988). A gene with sequence similarity to Drosophila engrailed is expressed during the development of the neural tube and vertebrae in the mouse. Development 104, 305-316.
7. Deckelbaum, R. A., Chan, G., Miao, D., Goltzman, D. and Karaplis, A. C. (2002). Ihh enhances differentiation of CFK-2 chondrocytic cells and antagonizes PTHrP-mediated activation of PKA. J. Cell Sci. 115, 3015-3025.
8. Eswarakumar, V. P., Monsonego-Ornan, E., Pines, M., Antonopoulou, I., Morriss-Kay, G. M. and Lonal, P. (2002). The IIIc alternative of Fgfr2 is a positive regulator of bone formation. Development 129, 3783-3793.
9. Eswarakumar, V. P., Horowitz, M. C., Locklin, R., Morriss-Kay, G. M. and Lonai, P. (2004). A gain-of-function mutation of Fgfr2c demonstrates the roles of this receptor variant in osteogenesis. Proc. Natl. Acad. Sci. USA 101, 12555-12560.
10. Fedde, K. N., Blair, L., Silverstein, J., Coburn, S. P., Ryan, L. M., Weinstein, R. S., Waymire, K., Narisawa, S., Millan, J. L., MacGregor, G. R. et al. (1999). Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J. Bone Miner. Res. 14, 2015-2026.
11. Furthauer, M., Lin, W., Ang, S. L., Thisse, B. and Thisse, C. (2002). Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling. Nat. Cell Biol. 4, 170-174.
12. Gori, F., Hofbauer, L. C., Dunstan, C. R., Spelsberg, T. C., Khosla, S. and Riggs, B. L. (2000). The expression of osteoprotegerin and RANK ligand and the support of osteoclast formation by stromal-osteoblast lineage cells is developmentally regulated. Endocrinology 141, 4768-4776.
13. Hanafusa, H., Torii, S., Yasunaga, T. and Nishida, E. (2002). Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 4, 850-858.
14. Hanks, M., Wurst, W., Anson-Cartwright L., Auerbach, A. B. and Joyner, A. L. (1995). Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 269, 679-682.
15. Holt, I., Davie, M. W., Braidman, I. P. and Marshall, M. J. (1994). Interleukin-6 does not mediate the stimulation by prostaglandin E2, parathyroid hormone, or 1,25 dihydroxyvitamin D3 of osteoclast differentiation and bone resorption in neonatal mouse parietal bones. Calcif. Tissue Int. 55, 114-119.
16. Ignelzi, M. A., Jr, Wang, W. and Young, A. T. (2003). Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures. J. Bone Miner. Res. 18, 751-759.
17. Iseki, S., Wilkie, A. O., Heath, J. K., Ishimaru, T., Eto, K. and Morriss-Kay, G. M. (1997). Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2. Development 124, 3375-3384.
18. Iseki, S., Wilkie, A. O. and Morriss-Kay, G. M. (1999). Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development 126, 5611-5620.
19. Ishii, M., Merrill, A. E., Chan, Y. S., Gitelman, I., Rice, D. P., Sucov, H. M. and Maxson, R. E., Jr (2003). Msx2 and Twist cooperatively control the development of the neural crest-derived skeletogenic mesenchyme of the murine skull vault. Development 130, 6131-6142.
20. Jiang, X., Iseki, S., Maxson, R. E., Sucov, H. M. and Morriss-Kay, G. M. (2002). Tissue origins and interactions in the mammalian skull vault. Dev. Biol. 241, 106-116.
21. Kawakami, Y., Rodriguez-Leon, J., Koth, C. M., Buscher, D., Itoh, T., Raya, A., Ng, J. K., Esteban, C. R., Takahashi, S., Henrique, D. et al. (2003). MKP3 mediates the cellular response to FGF8 signalling in the vertebrate limb. Nat. Cell Biol. 5, 513-519.
22. Kim, H. J., Rice, D. P., Kettunen, P. J. and Thesleff, I. (1998). FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development 125, 1241-1251.
23. Kim, H. J., Lee, M. H., Park, H. S., Park, M. H., Lee, S. W., Kim, S. Y., Choi, J. Y., Shin, H. I. and Ryoo, H. M. (2003). Erk pathway and activator protein 1 play crucial roles in FGF2-stimulated premature cranial suture closure. Dev. Dyn. 227, 335-346.
24. Komori, T., Yagi, H., Nomura, S., Yamaguchi, A., Sasaki, K., Deguchi, K., Shimizu, Y., Bronson, R. T., Gao, Y. H., Inacia, M. et al. (1997). Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764.
25. Kozawa, O., Tokuda, H., Matsuno, H. and Uematsu, T. (1999). Involvement of p38 mitogen-activated protein kinase in basic fibroblast growth factor-induced interleukin-6 synthesis in osteoblasts. J. Cell Biochem. 74, 479-485.
26. Lemonnier, J., Delannoy, P., Hott, M., Lomri, A., Modrowski, D. and Marie, P. J. (2000). The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp. Cell Res. 256, 158-167.
27. Lin, W., Furthauer, M., Thisse, B., Thisse, C., Jing, N. and Ang, S. L. (2002). Cloning of the mouse Sef gene and comparative analysis of its expression with Fgf8 and Spry2 during embryogenesis. Mech. Dev. 113, 163-168.
28. Lomri, A., Lemonnier, J., Delannoy, P. and Marie, P. J. (2001). Increased expression of protein kinase Calpha, interleukin-1 alpha, and RhoA guanosine 5'-triphosphatase in osteoblasts expressing the Ser252Trp fibroblast growth factor 2 receptor Apert mutation: identification by analysis of complementary DNA microarray. J. Bone Miner. Res. 16, 705-712.
29. Loomis, C. A., Harris, E., Michaud, J., Wurst, W., Hanks, M. and Joyner, A. L. (1996). The mouse Engrailed-1 gene and ventral limb patterning. Nature 382, 360-363.
30. Matise, M. P. and Joyner, A. L. (1997). Expression patterns of developmental control genes in normal and Engrailed-1 mutant mouse spinal cord reveal early diversity in developing interneurons. J. Neurosci. 17, 7805-7816.
31. Miao, D., Li, J., Xue, Y., Su, H., Karaplis, A. C. and Goltzman, D. (2004). Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice. Endocrinology 145, 3554-3562.
32. Minkin, C. (1982). Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif. Tissue Int. 34, 285-290.
33. Minowada, G., Jarvis, L. A., Chi, C. L., Neubuser, A., Sun, X., Hacohen, N., Krasnow, M. A. and Martin, G. R. (1999). Vertebrate Sprouty genes are induced by FGF signaling and can cause chondrodysplasia when overexpressed. Development 126, 4465-4475.
34. Murshed, M., Harmey, D., Milian, J. L., McKee, M. D. and Karsenty, G. (2005). Unique coexpression in osteolblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. Genes Dev 19, 1093-1104.
35. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R. and de Crombrugghe, B. (2002). The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29.
36. Newberry, E. P., Latifi, T. and Towler, D. A. (1998). Reciprocal regulation of osteocalcin transcription by the homeodomain proteins Msx2 and Dlx5. Biochemistry 37, 16360-16368.
37. Ohbayashi, N., Shibayama, M., Kurotaki, Y., Imanishi, M., Fujimori, T., Itoh, N. and Takada, S. (2002). FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev. 16, 870-879.
38. Opperman, L. A. (2000). Cranial sutures as intramembranous bone growth sites. Dev. Dyn. 219, 472-485.
39. Ornitz, D. M. and Marie, P. J. (2002). FGF signaling pathways in endochondral and intramembranous bone development and human genetic disease. Genes Dev. 16, 1446-1465.
40. Otto, F., Thornell, A. P., Crompton, T., Denzel, A., Gilmour, K. C., Rosewell, I. R., Stamp, G. W., Beddington, R. S., Mundlos, S., Olsen, B. R. et al. (1997). Cbfa1, a candidate gene for deidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771
41. Ozaki, K., Kadomoto, R., Asato, K., Tanimura, S., Itoh, N. and Kohno, M. (2001). ERK pathway positively regulates the expression of Sprouty genes. Biochem. Biophys. Res. Commun. 285, 1084-1088.
42. Rice, D. P., Kim, H. J. and Thesleff, I. (11997). Detection of gelatinase B expression reveals osteoclastic bone resorption as a feature of early calvarial bone development. Bone 21, 479-486.
43. Rice, D. P., Aberg, T., Chan, Y., Tang, Z., Kettunen, P. J., Pakarinen, L., Maxson, R. E. and Thesleff, I. (2000). Integration of FGF and TWIST in calvarial bone and suture development. Development 127, 1845-1855.
44. Robledo, R. F., Rajan, L., Li, X. and Lufkin, T. (2002). The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development. Genes Dev. 16, 1089-1101.
45. Satokata, I., Ma, L., Ohshima, H., Bei, M., Woo, I., Nishizawa, K., Maeda, T., Takano, Y., Llchiyama, M., Heaney, S. et al. (2000). Msx2 deficiency in mice causes pleiotropic defects in bone growth and ectodermal organ formation. Nat. Genet. 24, 391-395.
46. Takahashi, N., Udagawa, U., Takami, M. and Suda, T. (2002). Cells of bone: osteodast generation. In Principles of Bone Biology, Vol. 1 (ed. J. P. Bilezikian, L. G. Raisz and G. A. Rodan), pp. 109-126. New York: Academic Press.
47. Terai, K., Takano-Yamamoto, T., Ohba, Y., Hiura, K., Sugimoto, M., Sato, M., Kawahata, H., Inaguma, N., Kitamura, Y. and Nomura, S. (1999). Role of osteopontin in bone remodeling caused by mechanical stress. J. Bone Miner. Res. 14, 839-849.
48. Valverde-Franco, G., Liu, H., Davidson, D., Chai, S., Valderrama-Carvajal, H., Goltzman, D., Ornitz, D. M. and Henderson, J. E. (2004). Defective bone mineralization and osteopenia in young adult FGFR3-/- mice. Hum. Mol. Genet. 13, 271-284.
49. Wakioka, T., Sasaki, A., Kato, R., Shouda, T, Matsumoto, A., Miyoshi, K., Tsuneoka, M., Komiya, S., Baron, R. and Yoshimura, A. (2001). Spred is a Sprouty-related suppressor of Ras signalling. Nature 412, 647-651.
50. Webster, M. K. and Donoghue, D. J. (1996). Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia. EMBO J. 15, 520-527.
51. Wilkie, A. O. (1997). Craniosynostosis: genes and mechanisms. Hum. Mol. Genet. 6, 1647-1656.
52. Wilkie, A. O., Tang, Z., Elanko, N., Walsh, S., Twigg, S. R., Hurst, J. A., Wall, S. A., Chrzanowska, K. H. and Maxson, R. E., Jr (2000). Functional haploinsufficiency of the human homeobox gene MSX2 causes defects in skull ossification. Nat. Genet 24, 387-390.
53. Wurst, W., Auerbach, A. B. and Joyner, A. L. (1994). Multiple developmental defects in Engrailed-1 mutant mice: an early mid-hindbrain deletion and patterning defects in forelimbs and sternum. Development 120, 2065-2075.
54. Wuyts, W., Cleiren, E., Homfray, T., Rasore-Quartino, A., Vanhoenacker, F. and Van Hul, W. (2000). The ALX4 homeobox gene is mutated in patients with ossification defects of the skull (foramina parietalia permagna, OMIM 168500). J. Med. Genet. 37, 916-920.
55. Xiao, G., Jiang, D., Gopalakrishnan, R. and Franceschi, R. T. (2002). Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2. J. Biol. Chem. 277, 36181-36187.
56. Xu, Q., Wilkinson, D. G. (1999). In situ hybridization of mRNA with hapten labelled probes. In In Situ Hybridization: A Practical Approach (ed. D. G. Wilkinson), pp. 87-106. Oxford: Oxford University Press.
57. Yamazaki, M., Nakajima, F., Ogasawara, A., Moriya, H., Majeska, R. J. and Einhorn, T. A. (1999). Spatial and temporal distribution of CD44 and osteopontin in fracture callus. J. Bone Joint Surg. Br. 81, 508-515.
58. Yu, K., Xu, J., Liu, Z., Sosic, D., Shao, J., Olson, E. N., Towler, D. A. and Ornitz, D. M. (2003). Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth. Development 130, 3063-3074.
59. Zhang, S., Lin, Y., Itaranta, P., Yagi, A. and Vainio, S. (2001). Expression of Sprouty genes 1, 2 and 4 during mouse organogenesis. Mech. Dev. 109, 367-370.
60. Zhou, Y. X., Xu, X., Chen, L., Li, C., Brodie, S. G. and Deng, C. X. (2000). A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. Hum. Mol. Genet. 9, 2001-2008.